Cannabis-Infused Drinks: Exploring the New Beverage Trend

As the global soft-drink and alcohol consumption slows down, a growing number of companies think of cannabis beverages as a new growth vector. However, marketing cannabis-infused products could bring some reputational risks. An effective PR campaign can’t afford to ignore influencers with a well-established authority on this controversial subject. Using our media analytics tools, we … Continue reading “Cannabis-Infused Drinks: Exploring the New Beverage Trend”

Financial Crisis Anniversary: The Media’s Verdicts

Communication professionals working in finance could draw important lessons from the recent coverage of the financial crisis’ 10th anniversary – it encapsulates the PR problems that have been plaguing the industry for the last decade. Employing our media analytics tools, we examined how the coverage reflected the developments in economics, financial services, personal finances, regulation … Continue reading “Financial Crisis Anniversary: The Media’s Verdicts”

Alzheimer’s in the Media: The Power of Influencers

Due to the 99.6% failure rate of new Alzheimer’s drugs, scepticism is the default attitude in the media coverage of everything around the increasingly occurring disease. To tackle the inevitable reputation hurdles, communication professionals should take advantage from the fact that voices of authority within the pharma industry have regained credibility – the percentage of consumers … Continue reading “Alzheimer’s in the Media: The Power of Influencers”

The Future of Pharma? Mapping the Gene Therapy Trend

In their latest study on the pharma market, intelligence provider Evaluate pointed out that the development and commercialisation of gene and cell therapies is turning into a powerful engine of value creation for pharma companies. The launch of these novel therapies is also instrumental in fueling the global growth of the market, where total prescription … Continue reading “The Future of Pharma? Mapping the Gene Therapy Trend”

Big Pharma vs Big Tech: Healthcare Innovation Trends in the Media

“Part of our competitors are not only the Novartis of the world and the other pharmas, but really the Amazons and Googles,” Yitzhak Peterburg, the former CEO of pharmaceutical giant Teva, said a year ago, adding that the global healthcare sector is facing a “huge disruption” by tech giants which start competing with traditional players … Continue reading “Big Pharma vs Big Tech: Healthcare Innovation Trends in the Media”

US-China Trade War 2: Thought Leaders on the Battleground

As with the Brexit quandary, the economic turbulence surrounding the US-China trade skirmish presents an opportunity for many corporates to boost their brand presence in the media by establishing themselves as thought leaders. When reporting on the trade tensions between the two largest economies, journalists naturally reach out to quantitative analyses and expert studies, and … Continue reading “US-China Trade War 2: Thought Leaders on the Battleground”

US-China Trade War: Corporate Communications in the Battlefields

As the two largest national economies embroil in a trade showdown, it is individual companies which are in the centre of extensive reportages and economic commentary: the dispute is not just between the two countries, but also between corporations and policy makers, as the former are usually opposed to protectionist approaches. In the accelerating tit-for-tat … Continue reading “US-China Trade War: Corporate Communications in the Battlefields”

Deconstructing Pharma Reputation and Corporate Communication

The media can have a disproportionate impact on your company’s reputation, leading many to speak of ‘media reputation’, or the overall evaluation of an organization as presented in the media. Far be it from me to equate media coverage with corporate reputation, it may be argued that for companies in the pharmaceutical industry, how stakeholders … Continue reading “Deconstructing Pharma Reputation and Corporate Communication”